Circular RNAs and immunotherapy in retinoblastoma: emerging biomarkers and precision therapeutic strategies
Retinoblastoma (RB) immunotherapy represents a paradigm shift in managing this aggressive pediatric eye cancer, overcoming limitations of conventional therapies. Recent breakthroughs reveal how circular RNAs (circRNAs) critically modulate the tumor-imm…